Meeting report of the 2nd Lugano ExoDay: extracellular vesicles as next-generation clinical biomarkers and therapeutic agents

Carolina Balbi; Marina Cretich; Lucio Barile

doi:10.20517/evcna.2022.17

Extracellular Vesicles and Circulating Nucleic Acids ›› 2022, Vol. 3 ›› Issue (3) :189 -94. DOI: 10.20517/evcna.2022.17

Conference Report

Meeting report of the 2nd Lugano ExoDay: extracellular vesicles as next-generation clinical biomarkers and therapeutic agents

Author information +

History +

PDF

Cite this article

Download citation ▾

Carolina Balbi, Marina Cretich, Lucio Barile. Meeting report of the 2nd Lugano ExoDay: extracellular vesicles as next-generation clinical biomarkers and therapeutic agents. Extracellular Vesicles and Circulating Nucleic Acids, 2022, 3(3): 189-94 DOI:10.20517/evcna.2022.17

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Tóth EÁ,Visnovitz T.Formation of a protein corona on the surface of extracellular vesicles in blood plasma.J Extracell Vesicles2021;10:e12140 PMCID:PMC8439280

[2]	Kovács ÁF,Turiák L.The impact of circulating preeclampsia-associated extracellular vesicles on the migratory activity and phenotype of THP-1 monocytic cells.Sci Rep2018;8:5426

[3]	Keklikoglou I,Güç E.Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models.Nat Cell Biol2019;21:190-202 PMCID:PMC6525097

[4]	Grange C.Extracellular vesicles in kidney disease.Nat Rev Nephrol2022;18:499-513 PMCID:PMC9152665

[5]	Gori A,Greta B.Membrane-binding peptides for extracellular vesicles on-chip analysis.J Extracell Vesicles2020;9:1751428 PMCID:PMC7178839

[6]	Luque A,Krupinski J.Association between low levels of serum miR-638 and atherosclerotic plaque vulnerability in patients with high-grade carotid stenosis.J Neurosurg2018;131:72-9